CTLA4‐Ig prevents development of neutralizing antibody formation after continuous treatment with human FVIII in HA rats
Sign Up to like & getrecommendations! Published in 2022 at "Haemophilia"
DOI: 10.1111/hae.14573
Abstract: Immunogenicity causing development of anti‐drug antibodies (ADAs) are major challenges in the treatment of haemophilia, as well as other diseases where proteins are used for treatment. Furthermore, it is a complication for preclinical testing of… read more here.
Keywords: ctla4 prevents; development; neutralizing antibody; treatment ... See more keywords